Stock Information
Pacira Biosciences Inc (PCRX)
Ticker Symbol: PCRX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,000.91 mil
Piotroski score: 8
PE Ratio: 136.6715
EPS (TTM): 0.1571
Revenue (TTM): $16.90 M
Dividend Yield: N/A%
ROE: 0.95%
Latest News
-
RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $24
Fri, May 1, 2026 1:18 PM
-
Needham Maintains Buy on Pacira BioSciences, Raises Price Target to $32
Fri, May 1, 2026 7:22 AM
-
Pacira BioSciences, Inc. (PCRX) Q1 2026 Earnings Call Transcript
Thu, Apr 30, 2026 11:51 PM
-
Transcript : Pacira BioSciences, Inc., Q1 2026 Earnings Call, Apr 30, 2026
Thu, Apr 30, 2026 11:20 PM
-
Pacira BioSciences, Inc. 2026 Q1 - Results - Earnings Call Presentation
Thu, Apr 30, 2026 9:03 PM
-
Pacira Biosciences (NASDAQ:PCRX) Q1 2026 Results Beat Estimates as Key Pipeline Catalysts Near
Thu, Apr 30, 2026 9:01 PM
-
Pacira BioSciences : Corporate Sustainability Report (pacira corporate sustainability report 2024 v1 20260430)
Thu, Apr 30, 2026 8:06 PM
-
Pacira BioSciences Q1 2026 Earnings Call Transcript
Thu, Apr 30, 2026 5:27 PM
-
Pacira: Q1 Earnings Snapshot
Thu, Apr 30, 2026 4:31 PM
-
Pacira BioSciences Affirms FY2026 Sales Guidance of $745.000M-$770.000M vs $759.317M Est
Thu, Apr 30, 2026 4:02 PM
Key Financials
Financial data not available
